v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Ordinary Shares
Ordinary Shares
Performance-Based Restricted Stock Units (PRSUs)
Non-voting Euro Deferred
Capital Redemption Reserve
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022   63,214   4,000        
Beginning balance at Dec. 31, 2022 $ 3,085,734 $ 6   $ 55 $ 472 $ 3,477,124 $ (1,125,509) $ 733,586
Increase (Decrease) in Shareholders' Equity [Roll Forward]                
Issuance of ordinary shares in conjunction with exercise of share options (in shares)   280            
Issuance of ordinary shares in conjunction with exercise of share options 30,189         30,189    
Issuance of ordinary shares under employee stock purchase plan (in shares)   156            
Issuance of ordinary shares under employee stock purchase plan 16,270         16,270    
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)   735            
Shares withheld for payment of employee's withholding tax liability (50,952)         (50,952)    
Share-based compensation 227,323         227,323    
Shares repurchased (in shares)   (2,130)            
Shares repurchased (269,761)       1     (269,762)
Other comprehensive income (loss) 283,362           283,362  
Net income (loss) 414,832             414,832
Ending balance (in shares) at Dec. 31, 2023   62,255   4,000        
Ending balance at Dec. 31, 2023 3,736,997 $ 6   $ 55 473 3,699,954 (842,147) 878,656
Increase (Decrease) in Shareholders' Equity [Roll Forward]                
Issuance of ordinary shares in conjunction with exercise of share options (in shares)   22            
Issuance of ordinary shares in conjunction with exercise of share options 1,629         1,629    
Issuance of ordinary shares under employee stock purchase plan (in shares)   212            
Issuance of ordinary shares under employee stock purchase plan 19,018         19,018    
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)   892 80          
Shares withheld for payment of employee's withholding tax liability (57,753)         (57,753)    
Share-based compensation 250,694         250,694    
Shares repurchased (in shares)   (2,830)            
Shares repurchased (311,429)             (311,429)
Other comprehensive income (loss) (105,520)           (105,520)  
Net income (loss) $ 560,120             560,120
Ending balance (in shares) at Dec. 31, 2024 60,631 60,631   4,000        
Ending balance at Dec. 31, 2024 $ 4,093,756 $ 6   $ 55 473 3,913,542 (947,667) 1,127,347
Increase (Decrease) in Shareholders' Equity [Roll Forward]                
Issuance of ordinary shares in conjunction with exercise of share options (in shares) 658 668            
Issuance of ordinary shares in conjunction with exercise of share options $ 88,470         88,470    
Issuance of ordinary shares under employee stock purchase plan (in shares)   215            
Issuance of ordinary shares under employee stock purchase plan 19,393         19,393    
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)   964 99          
Shares withheld for payment of employee's withholding tax liability (75,220)         (75,220)    
Share-based compensation 294,287         294,287    
Shares repurchased (in shares)   (1,142)            
Shares repurchased (125,023)             (125,023)
Other comprehensive income (loss) 379,069           379,069  
Net income (loss) $ (356,148)             (356,148)
Ending balance (in shares) at Dec. 31, 2025 61,435 61,435   4,000        
Ending balance at Dec. 31, 2025 $ 4,318,584 $ 6   $ 55 $ 473 $ 4,240,472 $ (568,598) $ 646,176